Literature DB >> 15764731

Endothelial L-selectin ligands in sinus mucosa during chronic maxillary rhinosinusitis.

Sanna K Toppila-Salmi1, Jyri P Myller, Tommi V M Torkkeli, Jarkko V Muhonen, Jutta A Renkonen, Markus E Rautiainen, Risto L O Renkonen.   

Abstract

RATIONALE: Chronic rhinosinusitis is characterized by persistent inflammation of the nasal and paranasal mucosa with numerous emigrated leukocytes. L-selectin on leukocytes and its endothelial glycosylated ligands initiate organ-specific leukocyte infiltration into inflamed tissues.
OBJECTIVES: The purpose of this study was to evaluate the endothelial expression of functionally active endothelial L-selectin ligands, sulfated sialyl Lewis x, in maxillary sinus mucosa from patients with chronic rhinosinusitis and from normal control subjects.
METHODS: Maxillary sinus mucosa specimens (116) were obtained surgically and immunohistochemically stained with monoclonal antibodies detecting sialyl Lewis x or sulfated extended core 1 lactosamines. The severity of the inflammation was determined by intraoperative endoscopic findings, computed tomography scans, and histopathologic assessment of the specimens.
MEASUREMENTS AND MAIN RESULTS: The percentage of vessels expressing endothelial sulfated sialyl Lewis x epitopes increased during chronic rhinosinusitis compared with uninflamed control tissue, especially in patients with additional allergic rhinitis, and decreased in specimens from aspirin-intolerant patients with preoperative oral corticosteroid treatment. In addition, the expression level of endothelial sulfated sialyl Lewis x epitopes and the number of mucosal eosinophils correlated with the severity of the inflammation, and decreased in specimens taken 9 months postoperatively compared with intraoperative samples, especially in patients with intranasal corticosteroid treatment.
CONCLUSIONS: Our results suggest that functionally active L-selectin ligands might guide leukocyte traffic into maxillary sinus mucosa preferentially in patients with severe findings of chronic maxillary rhinosinusitis, thus leading to aggravation of the inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764731     DOI: 10.1164/rccm.200406-775OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

1.  Mechanism of action and efficacy of RX-111, a thieno[2,3-c]pyridine derivative and small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), in delayed-type hypersensitivity, TNBS-induced colitis and experimental autoimmune encephalomyelitis.

Authors:  Nicholas Harris; Juraj Koppel; Ferenc Zsila; Stefan Juhas; Gabriela Il'kova; Faina Yurgenzon Kogan; Orly Lahmy; Gizi Wildbaum; Nathan Karin; Regina Zhuk; Paul Gregor
Journal:  Inflamm Res       Date:  2016-01-21       Impact factor: 4.575

2.  Characterisation of interleukin-10 expression on different vascular structures in allergic nasal mucosa.

Authors:  Barbara Muller; Danielle van Egmond; Esther Jj de Groot; Wytske J Fokkens; Cornelis M van Drunen
Journal:  Clin Transl Allergy       Date:  2014-01-10       Impact factor: 5.871

3.  Satisfaction with maxillary sinus surgery might be influenced by risk factors.

Authors:  Jyri P Myller; Annika T Luukkainen; Heini S A Huhtala; Tommi V M Torkkeli; Markus E P Rautiainen; Sanna K Toppila-Salmi
Journal:  Allergy Rhinol (Providence)       Date:  2013

4.  Factors affecting revision rate of chronic rhinosinusitis.

Authors:  Anni Koskinen; Riikka Salo; Heini Huhtala; Jyri Myller; Markus Rautiainen; Janne Kääriäinen; Matti Penttilä; Risto Renkonen; Hannu Raitiola; Mika Mäkelä; Sanna Toppila-Salmi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-07-05

Review 5.  High endothelial venules (HEVs) in immunity, inflammation and cancer.

Authors:  Lucas Blanchard; Jean-Philippe Girard
Journal:  Angiogenesis       Date:  2021-05-06       Impact factor: 9.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.